A clinical trial of an mpox vaccine in adolescents found it was safe and generated an antibody response equivalent to that seen in adults. The interim results of this National Institutes of Health (NIH)-funded trial were presented at the IDWeek2024 conference in Los Angeles. Colourised transmission… Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week we learned the shocking statistic that… Read More
News round-up for 7-11 November by DDW Digital Content Editor Diana Spencer This week we learned the shocking statistic that a third of scientific researchers have, or know a close colleague who has, experienced abuse after posting research online. It wasn’t all bad news, however, as top… Read More
A team of scientists has identified the specific mutations in the monkeypox virus that contribute to its continued infectiousness. Monkeypox has infected more than 77,000 people in more than 100 countries worldwide. Mutations have enabled the virus to grow stronger and smarter, evading antiviral drugs and… Read More
The Rockefeller Foundation will provide $3 million in new funding for Global.health (G.h) – an open-source platform for scientific pandemic data. The investment will allow the platform to expand its international partnerships and modernise the global effort around coordinated pandemic prevention, surveillance, and response. Co-developed by researchers and engineers… Read More
A new study has found that the antiviral tecovirimat (TPOXX) appears to be safe and effective for the treatment of monkeypox symptoms and skin lesions. This University of California Davis Health (UC Davis Health) study is one of the earliest studies to assess and report the outcomes of treating patients… Read More
News round-up for 21-25 August by DDW Editor Reece Armstrong A treatment for Monkeypox, spider venom for drug discovery and funding for international start-ups are some of the stories in this week’s news round-up. Covid researchers launch Monkeypox study A new study investigating a potential treatment… Read More
A new study investigating a potential treatment for people who have been diagnosed with monkeypox has been launched by the same team who helped develop Covid-19 treatments. Led by the University of Oxford, the PLATINUM study will investigate the use of Tecovirimat to see if it can… Read More
Pharmaceutical company SIGA Technologies has announced that its oral therapy tecovirimat has been approved in the UK for the treatment of smallpox, monkeypox, cowpox. The therapy has also been approved for the treatment of complications following vaccination against smallpox in adults and children with a body weight… Read More
News round-up by DDW’s Reece Armstrong for 27 – 30 June. Assays for monkeypox, Covid-19 boosters and approvals for oncology drugs are some of the themes of this week’s news round-up. GSK & Sanofi first to report positive data for Omicron booster GSK and Sanofi have reported positive efficacy… Read More
Clinical diagnostics company Novacyt has launched a polymerase chain reaction (PCR) monkeypox assay in response to the recent outbreak of the virus non-endemic countries. The company’s monkeypox assay is for research-use only (RUO) and has been developed in two forms for the detection of the virus genome in… Read More
